PBH · NYSE
Prestige Consumer Healthcare (PBH) Stock Price & Fundamentals
Prestige Consumer Healthcare (PBH) closed at $628.89 on Oct 9, 2026, up 1.30% from the previous close of $620.83.
Share price, past year
1Y +23.88%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $628.89 |
| Sep 30, 2026 | $612.41 |
| Aug 31, 2026 | $576.17 |
| Jul 31, 2026 | $567.27 |
| Jun 30, 2026 | $539.54 |
| May 29, 2026 | $530.94 |
| Apr 30, 2026 | $518.67 |
| Mar 31, 2026 | $543.17 |
| Feb 27, 2026 | $542.77 |
| Jan 30, 2026 | $535.93 |
| Dec 31, 2025 | $561.65 |
| Nov 28, 2025 | $541.45 |
| Oct 31, 2025 | $525.51 |
Key statistics
- Market cap
- $29.79B
- P/E (TTM)
- 176.2
- EPS (TTM)
- $3.57
- Revenue (TTM)
- $1.10B
- Net income (TTM)
- $172.01M
- Shares outstanding
- 47.4M
- Dividend yield
- —
- 52-week range
- $503.65 – $628.89
Prestige Consumer Healthcare's market cap is $29.79B, based on a share price of $628.89 and 47.4M shares outstanding as of May 12, 2026.
Financials
Prestige Consumer Healthcare reported revenue of $1.09B for fiscal 2026, down 4.31% from fiscal 2025.
Prestige Consumer Healthcare earned net income of $190.30M in fiscal 2026, a net margin of 17.5%.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Mar 31, 2026 | $1.09B | −4.3% | $190.30M | 17.5% | $3.91 | $246.45M |
| FY2025ended Mar 31, 2025 | $1.14B | +1.1% | $214.61M | 18.9% | $4.29 | $243.29M |
| FY2024ended Mar 31, 2024 | $1.13B | −0.2% | $209.34M | 18.6% | $4.17 | $239.38M |
| FY2023ended Mar 31, 2023 | $1.13B | +3.8% | −$82.31M | −7.3% | −$1.65 | $221.93M |
| FY2022ended Mar 31, 2022 | $1.09B | +15.2% | $205.38M | 18.9% | $4.04 | $250.28M |
| FY2021ended Mar 31, 2021 | $943.37M | −2.0% | $164.68M | 17.5% | $3.25 | $213.36M |
| FY2020ended Mar 31, 2020 | $963.01M | −1.3% | $142.28M | 14.8% | $2.78 | $202.56M |
| FY2019ended Mar 31, 2019 | $975.78M | −6.3% | −$35.80M | −3.7% | −$0.69 | $178.80M |
| FY2018ended Mar 31, 2018 | $1.04B | +18.0% | $339.57M | 32.6% | $6.34 | $197.58M |
| FY2017ended Mar 31, 2017 | $882.06M | — | $69.40M | 7.9% | $1.30 | $145.70M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2027ended Jun 30, 2026 | $265.71M | $29.18M | $0.61 |
| Q4 FY2026ended Mar 31, 2026 | $281.62M | $53.93M | $1.13 |
| Q3 FY2026ended Dec 31, 2025 | $283.44M | $46.70M | $0.97 |
| Q2 FY2026ended Sep 30, 2025 | $274.11M | $42.21M | $0.86 |
| Q1 FY2026ended Jun 30, 2025 | $249.53M | $47.47M | $0.95 |
| Q4 FY2025ended Mar 31, 2025 | $296.52M | $50.13M | $1.00 |
| Q3 FY2025ended Dec 31, 2024 | $290.32M | $61.03M | $1.22 |
| Q2 FY2025ended Sep 30, 2024 | $283.79M | $54.38M | $1.09 |
Company profile
- Name
- Prestige Consumer Healthcare Inc.
- Ticker
- PBH
- Exchange
- NYSE
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 660 White Plains Rd., Tarrytown, NY 10591
- Fiscal year ends
- March
- SEC CIK
- 0001295947
Recent SEC filings
- Aug 14, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jul 15, 2026
- Jul 6, 2026
- Jun 16, 2026
- May 14, 2026
- May 13, 2026
Frequently asked questions
What is Prestige Consumer Healthcare's stock price?
Prestige Consumer Healthcare (PBH) closed at $628.89 on Oct 9, 2026, up 1.30% from the previous close of $620.83.
What is Prestige Consumer Healthcare's market cap?
Prestige Consumer Healthcare's market cap is $29.79B, based on a share price of $628.89 and 47.4M shares outstanding as of May 12, 2026.
How much revenue does Prestige Consumer Healthcare make?
Prestige Consumer Healthcare reported revenue of $1.09B for fiscal 2026, down 4.31% from fiscal 2025.
What is PBH's P/E ratio?
Prestige Consumer Healthcare's price-to-earnings ratio is 176.2, based on trailing twelve-month diluted EPS of $3.57.
Does Prestige Consumer Healthcare pay a dividend?
Prestige Consumer Healthcare's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Prestige Consumer Healthcare Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures